[Studies on contrast medium dosage in perfusion-weighted MR imaging]

Rofo. 1997 Dec;167(6):599-604. doi: 10.1055/s-2007-1015589.
[Article in German]

Abstract

Purpose: In this study we investigated, whether increasing the dosage of a paramagnetic contrast agent results in a stronger signal decrease in T2*-weighted perfusion sequences and therefore more meaningful parameter maps.

Material and methods: In a prospective study bolus injection of gadolinium-DTPA was performed at dosages of 0.1, 0.2, and 0.3 mmol/kg body weight (BW) in 10 patients each. Before, during and after bolus injection 40 T2*-weighted images of a reference brain slice were acquired within 65.6 seconds on a 1.0 T clinical scanner and perfusion parameters were calculated.

Results: Due to the limited signal decrease during bolus passage and the resulting low signal-difference-to-noise ratio (delta S/N) no reliable differentiation of gray and white matter was possible at a contrast agent dosage of 0.1 mmol/kg BW. Only at higher dosages, both, signal decrease and delta S/N were strong enough to allow differentiation of gray and white matter and to yield reliable parameter maps.

Conclusion: For meaningful MR perfusion imaging at 1.0 T and with the given sequence a contrast agent dosage of at least 0.2 mmol/kg BW is necessary, if a 0.5-molar contrast agent is used.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Brain / anatomy & histology*
  • Cerebrovascular Circulation*
  • Contrast Media / administration & dosage*
  • Gadolinium DTPA / administration & dosage*
  • Humans
  • Injections, Intravenous
  • Magnetic Resonance Imaging / methods*
  • Middle Aged
  • Prospective Studies

Substances

  • Contrast Media
  • Gadolinium DTPA